Article
Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization.
Immunity - 8 Feb 2022
Weber Timm, Potthoff Julian, Bizu Sven, Labuhn Maurice, Dold Leona, Schoofs Till, Horning Marcel, Ercanoglu Meryem S, Kreer Christoph, Gieselmann Lutz, Vanshylla Kanika, Langhans Bettina, Janicki Hanna, Ströh Luisa J, Knops Elena, Nierhoff Dirk, Spengler Ulrich, Kaiser Rolf, Bjorkman Pamela J, Krey Thomas, Bankwitz Dorothea, Pfeifer Nico, Pietschmann Thomas, Flyak Andrew I, Klein Florian
Abstract excerpt
The high genetic diversity of hepatitis C virus (HCV) complicates effective vaccine development. We screened a cohort of 435 HCV-infected individuals and found that 2%-5% demonstrated outstanding HCV-neutralizing activity. From four of these patients, we isolated 310 HCV antibodies, including neutralizing antibodies with exceptional breadth and potency. High neutralizing activity was enabled by the use of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
